Invivyd
innovative antibody medicines development
- B2B
About Invivyd
Development of potent monoclonal antibodies using proprietary technology platform to combat virus evolution and enhance immune response effectiveness.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- New Haven, Connecticut, United States
- Founded
- 2020
- Revenue
- $53.4MFY2025, publicly reported
- Website
- invivyd.com
- linkedin.com/company/invivyd
Invivyd at a glance
Invivyd is a B2B company in the Biotechnology Research industry, headquartered in New Haven, Connecticut, United States.
Invivyd was founded in 2020.
Invivyd has 51–250 employees.
Invivyd's revenue is $53.4M (FY2025, publicly reported).
Selling to companies like Invivyd?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies